{"pmid":32304463,"title":"COVID-19 putting patients at risk of unplanned extubation and airway providers at increased risk of contamination.","text":["COVID-19 putting patients at risk of unplanned extubation and airway providers at increased risk of contamination.","Anesth Analg","Berkow, Lauren","Kanowitz, Arthur","32304463"],"journal":"Anesth Analg","authors":["Berkow, Lauren","Kanowitz, Arthur"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304463","week":"202016|Apr 13 - Apr 19","doi":"10.1213/ANE.0000000000004890","source":"PubMed","topics":["Prevention","Treatment"],"weight":1,"_version_":1664431720492957696,"score":8.233237,"similar":[{"pmid":32303376,"title":"Extubation of patients with COVID-19.","text":["Extubation of patients with COVID-19.","Br J Anaesth","D'Silva, David F","McCulloch, Timothy J","Lim, Jessica S","Smith, Sanchia S","Carayannis, Daniel","32303376"],"journal":"Br J Anaesth","authors":["D'Silva, David F","McCulloch, Timothy J","Lim, Jessica S","Smith, Sanchia S","Carayannis, Daniel"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303376","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.bja.2020.03.016","keywords":["covid-19","aerosol generating procedure","airway management","coronavirus","mechanical ventilation","tracheal extubation"],"source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"_version_":1664431720418508800,"score":76.8524},{"pmid":32259547,"title":"COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions?","text":["COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions?","J Hosp Infect","De Vitis, Rocco","Passiatore, Marco","Perna, Andrea","Proietti, Luca","Taccardo, Giuseppe","32259547"],"journal":"J Hosp Infect","authors":["De Vitis, Rocco","Passiatore, Marco","Perna, Andrea","Proietti, Luca","Taccardo, Giuseppe"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259547","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jhin.2020.03.037","keywords":["COVID-19","Coronavirus","Hand Hygiene","healthcare workers","trauma"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663450393503334400,"score":71.90435},{"pmid":32275971,"title":"COVID-19 in patients with diabetes: risk factors that increase morbidity.","text":["COVID-19 in patients with diabetes: risk factors that increase morbidity.","Metabolism","Klonoff, David C","Umpierrez, Guillermo E","32275971"],"journal":"Metabolism","authors":["Klonoff, David C","Umpierrez, Guillermo E"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275971","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.metabol.2020.154224","keywords":["COVID-19","Corticosteroid","Diabetes","Risk","Telemedicine"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663712077896744962,"score":68.30847},{"pmid":32171062,"pmcid":"PMC7118626","title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","text":["Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","Lancet Respir Med","Fang, Lei","Karakiulakis, George","Roth, Michael","32171062"],"journal":"Lancet Respir Med","authors":["Fang, Lei","Karakiulakis, George","Roth, Michael"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32171062","week":"202011|Mar 09 - Mar 15","doi":"10.1016/S2213-2600(20)30116-8","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352133961908225,"score":65.44263},{"pmid":32215548,"title":"Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?","text":["Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?","Crohn's disease (CD)] and ulcerative colitis (UC), the main inflammatory bowel diseases (IBD) in human beings, are chronic, immune-inflammatory diseases, whose pathogenesis implicates a complex interaction between environmental factors and genetic susceptibility. These disabling conditions affect millions of individuals and, together with the drugs used to treat them, can put patients at risk of developing complications and other conditions. This is particularly relevant nowadays, as coronavirus disease (Covid-19) has rapidly spread from China to countries where IBD are more prevalent and there is convincing evidence that Covid-19-mediated morbidity and mortality are higher in subjects with comorbidities. The primary objectives of this Viewpoint are to provide a focused overview of the factors and mechanisms by which the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the cells and to illustrate the link between such determinants and the intestinal inflammation. We also provide clues about the reasons why the overall IBD population might have no increased risk to be infected with SARS-CoV-2 and highlight the potential of cytokine blockers, used to treat IBD patients, to prevent Covid-driven pneumonia.","J Crohns Colitis","Monteleone, Giovanni","Ardizzone, Sandro","32215548"],"abstract":["Crohn's disease (CD)] and ulcerative colitis (UC), the main inflammatory bowel diseases (IBD) in human beings, are chronic, immune-inflammatory diseases, whose pathogenesis implicates a complex interaction between environmental factors and genetic susceptibility. These disabling conditions affect millions of individuals and, together with the drugs used to treat them, can put patients at risk of developing complications and other conditions. This is particularly relevant nowadays, as coronavirus disease (Covid-19) has rapidly spread from China to countries where IBD are more prevalent and there is convincing evidence that Covid-19-mediated morbidity and mortality are higher in subjects with comorbidities. The primary objectives of this Viewpoint are to provide a focused overview of the factors and mechanisms by which the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the cells and to illustrate the link between such determinants and the intestinal inflammation. We also provide clues about the reasons why the overall IBD population might have no increased risk to be infected with SARS-CoV-2 and highlight the potential of cytokine blockers, used to treat IBD patients, to prevent Covid-driven pneumonia."],"journal":"J Crohns Colitis","authors":["Monteleone, Giovanni","Ardizzone, Sandro"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32215548","week":"202013|Mar 23 - Mar 29","doi":"10.1093/ecco-jcc/jjaa061","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352134975881216,"score":65.44263}]}